<DOC>
	<DOCNO>NCT00774046</DOCNO>
	<brief_summary>The purpose study determine effectiveness particular combination drug use treat cancer .</brief_summary>
	<brief_title>High-dose Cytarabine/Mitoxantrone Followed Autotransplantation t-MDS/t-AML</brief_title>
	<detailed_description />
	<mesh_term>Syndrome</mesh_term>
	<mesh_term>Leukemia</mesh_term>
	<mesh_term>Leukemia , Myeloid</mesh_term>
	<mesh_term>Leukemia , Myeloid , Acute</mesh_term>
	<mesh_term>Myelodysplastic Syndromes</mesh_term>
	<mesh_term>Preleukemia</mesh_term>
	<mesh_term>Etoposide</mesh_term>
	<mesh_term>Mitoxantrone</mesh_term>
	<mesh_term>Etoposide phosphate</mesh_term>
	<mesh_term>Cytarabine</mesh_term>
	<criteria>Patients must receive cytotoxic chemotherapy , radiation , drug know affect property DNA cell growth condition acute myeloid leukemia prior diagnosis . Patients must tMDS/tAML To eligible allogeneic transplantation , patient must suitable donor HLA compatible . Patients must age 10 . Patients must review discussed Leukemia Transplant Conferences Section Hematology/Oncology . Patients must serious medical condition ( e.g.uncontrolled severe cardiovascular disease , diabetes , pulmonary disease , infection ) Psychiatric condition would prevent compliance possibly worsen treatment</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2014</verification_date>
	<keyword>Therapy-related myelodysplastic syndrome/ Therapy -related Acute myeloid leukemia</keyword>
	<keyword>Myelodysplastic syndrome</keyword>
	<keyword>Acute myeloid leukemia</keyword>
</DOC>